DEBORAH RISTVEDT
- Type
- Physician · Allopathic & Osteopathic Physicians / Ophthalmology
- Where
- ALEXANDRIA, MN
- NPI
- 1871881656
- Received
- $633,214 in 305 records, 2019 to 2025 ($391,591 general, $241,622 research)
- As principal investigator
- $866,549 of research payments to others in 279 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 54 | $187,723 |
| 2024 | General payment | 48 | $50,243 |
| 2024 | Research payment | 1 | $166 |
| 2023 | General payment | 36 | $60,383 |
| 2023 | Research payment | 10 | $241,272 |
| 2022 | General payment | 26 | $14,022 |
| 2022 | Research payment | 2 | $184 |
| 2021 | General payment | 40 | $24,822 |
| 2020 | General payment | 40 | $37,358 |
| 2019 | General payment | 48 | $17,037 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Beaver-Visitec International, Inc. | 3 | $391,881 | 2023–2025 |
| Glaukos Corporation | 76 | $81,854 | 2019–2025 |
| RxSight Inc | 26 | $53,864 | 2022–2024 |
| Sight Sciences, Inc. | 59 | $52,802 | 2019–2025 |
| Allergan, Inc. | 44 | $24,013 | 2019–2022 |
| Alcon Vision LLC | 55 | $9,625 | 2019–2025 |
| Johnson & Johnson Surgical Vision, Inc. | 3 | $5,743 | 2022–2024 |
| ABBVIE INC. | 10 | $3,979 | 2022–2025 |
| Rayner Intraocular Lenses Limited | 5 | $3,958 | 2023–2025 |
| Tarsus Pharmaceuticals, Inc. | 2 | $1,588 | 2025 |
| Novartis Pharmaceuticals Corporation | 4 | $1,295 | 2021–2023 |
| Alcon Research LLC | 1 | $1,050 | 2020 |
| Thea Pharma Inc. | 1 | $975 | 2023 |
| Johnson & Johnson Vision Care, Inc. | 2 | $197 | 2024 |
| Harrow Eye, LLC | 3 | $75 | 2024–2025 |
| Carl Zeiss Meditec, Inc. | 1 | $64 | 2019 |
| Aerie Pharmaceuticals, Inc. | 1 | $49 | 2019 |
| Omeros Corporation | 1 | $40 | 2021 |
| Oyster Point Pharma, Inc. | 2 | $34 | 2023–2025 |
| BIOTISSUE HOLDINGS INC. | 2 | $33 | 2024 |
| Dompe US, Inc. | 1 | $33 | 2024 |
| The Cameron-Ehlen Group, Inc. | 1 | $22 | 2021 |
| NEW WORLD MEDICAL,INC. | 1 | $15 | 2022 |
| Horizon Therapeutics plc | 1 | $14 | 2022 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Consulting Fee | 88 | $332,375 |
| Research payment | 13 | $241,622 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 23 | $31,578 |
| Honoraria | 13 | $17,275 |
| Food and Beverage | 153 | $6,249 |
| Travel and Lodging | 14 | $4,066 |
| Gift | 1 | $45 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-11-19 | Glaukos Corporation | $1,750 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-11-11 | Alcon Vision LLC | $16 | Food and Beverage | In-kind items and services | Clareon Device, Ophthalmology | 2025 | |
| 2025-11-04 | Alcon Vision LLC | $7 | Food and Beverage | In-kind items and services | Clareon Device, Ophthalmology | 2025 | |
| 2025-11-03 | Rayner Intraocular Lenses Limited | $1,610 | Consulting Fee | Cash or cash equivalent | RayOne EMV Device, Ophthalmology | 2025 | |
| 2025-10-31 | Beaver-Visitec International, Inc. | $148,517 | Consulting Fee (5 payments) | Cash or cash equivalent | 2025 | ||
| 2025-10-28 | Alcon Vision LLC | $25 | Food and Beverage | In-kind items and services | Clareon Device, Ophthalmology | 2025 | |
| 2025-10-09 | Glaukos Corporation | $28 | Food and Beverage | Cash or cash equivalent | iStent infinite Device, Ophthalmology | 2025 | |
| 2025-10-08 | Glaukos Corporation | $1,750 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-09-24 | Glaukos Corporation | $437 | Consulting Fee | Cash or cash equivalent | Travoprost Intraocular Implant - iDose Drug, Ophthalmology | 2025 | |
| 2025-09-18 | Sight Sciences, Inc. | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-09-18 | Alcon Vision LLC | $20 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-17 | Sight Sciences, Inc. | $69 | Food and Beverage | In-kind items and services | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-09-10 | Glaukos Corporation | $1,750 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-09-09 | Alcon Vision LLC | $15 | Food and Beverage | In-kind items and services | HYDRUS Microstent Device, Ophthalmology | 2025 | |
| 2025-07-23 | Harrow Eye, LLC | $21 | Food and Beverage | In-kind items and services | VEVYE Drug, OPTOMETRY | 2025 | |
| 2025-07-10 | Alcon Vision LLC | $2,000 | Consulting Fee | Cash or cash equivalent | Voyager DSLT Device, Ophthalmology | 2025 | |
| 2025-06-26 | Alcon Vision LLC | $54 | Food and Beverage | In-kind items and services | Clareon PanOptix Pro Device, Ophthalmology | 2025 | |
| 2025-06-25 | Glaukos Corporation | $41 | Food and Beverage | Cash or cash equivalent | iDoseTR Drug, Ophthalmology | 2025 | |
| 2025-06-16 | Alcon Vision LLC | $15 | Food and Beverage | In-kind items and services | HYDRUS Microstent Device, Ophthalmology | 2025 | |
| 2025-06-11 | Glaukos Corporation | $1,500 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-05-22 | Alcon Vision LLC | $2,500 | Consulting Fee | Cash or cash equivalent | Voyager DSLT Device, Ophthalmology | 2025 | |
| 2025-05-20 | Glaukos Corporation | $20 | Food and Beverage | Cash or cash equivalent | iStent inject W Device, Ophthalmology | 2025 | |
| 2025-05-14 | Glaukos Corporation | $3,750 | Consulting Fee | Cash or cash equivalent | Travoprost Intraocular Implant - iDose Drug, Ophthalmology | 2025 | |
| 2025-05-14 | Glaukos Corporation | $1,500 | Consulting Fee | Cash or cash equivalent | iStent infinite Device, Ophthalmology | 2025 | |
| 2025-05-14 | ABBVIE INC. | $450 | Consulting Fee | Cash or cash equivalent | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-05-14 | Glaukos Corporation | $73 | Travel and Lodging | Cash or cash equivalent | 2025 | ||
| 2025-05-12 | Oyster Point Pharma, Inc. | $20 | Food and Beverage | In-kind items and services | TYRVAYA Drug, Dry eyes | 2025 | |
| 2025-05-08 | Sight Sciences, Inc. | $3,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-05-08 | Sight Sciences, Inc. | $375 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-05-07 | Glaukos Corporation | $1,500 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-04-27 | Rayner Intraocular Lenses Limited | $36 | Food and Beverage | Cash or cash equivalent | RAYNER CATARACT SET 1 Device, Ophthalmology | 2025 | |
| 2025-04-27 | Harrow Eye, LLC | $30 | Food and Beverage | In-kind items and services | VEVYE Drug, OPTOMETRY | 2025 | |
| 2025-04-26 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-04-25 | Glaukos Corporation | $5 | Food and Beverage | Cash or cash equivalent | iDoseTR Drug, Ophthalmology | 2025 | |
| 2025-04-16 | Glaukos Corporation | $1,500 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-04-10 | Glaukos Corporation | $79 | Food and Beverage | Cash or cash equivalent | iDoseTR Drug, Ophthalmology | 2025 | |
| 2025-04-09 | Glaukos Corporation | $17 | Food and Beverage | Cash or cash equivalent | iStent inject W Device, Ophthalmology | 2025 | |
| 2025-04-07 | Rayner Intraocular Lenses Limited | $2,260 | Consulting Fee | Cash or cash equivalent | RayOne EMV Device, Ophthalmology | 2025 | |
| 2025-04-01 | Tarsus Pharmaceuticals, Inc. | $1,500 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-03-19 | Glaukos Corporation | $135 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-03-12 | Glaukos Corporation | $2,250 | Consulting Fee | Cash or cash equivalent | Travoprost Intraocular Implant - iDose Drug, Ophthalmology | 2025 | |
| 2025-03-12 | Glaukos Corporation | $1,500 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-03-12 | Sight Sciences, Inc. | $750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-03-07 | Alcon Vision LLC | $144 | Food and Beverage | In-kind items and services | Centurion Device, Ophthalmology | 2025 | |
| 2025-03-05 | Glaukos Corporation | $26 | Food and Beverage | Cash or cash equivalent | iStent inject W Device, Ophthalmology | 2025 | |
| 2025-02-26 | Glaukos Corporation | $1,500 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-02-26 | Glaukos Corporation | $1,500 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-02-26 | ABBVIE INC. | $34 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-02-24 | Alcon Vision LLC | $18 | Food and Beverage | In-kind items and services | EYSUVIS Drug, Ophthalmology | 2025 | |
| 2025-02-11 | Alcon Vision LLC | $21 | Food and Beverage | In-kind items and services | HYDRUS Microstent Device, Ophthalmology | 2025 | |
| 2025-01-21 | Glaukos Corporation | $176 | Food and Beverage | Cash or cash equivalent | iDoseTR Drug, Ophthalmology | 2025 | |
| 2025-01-20 | Glaukos Corporation | $53 | Food and Beverage | Cash or cash equivalent | iDoseTR Drug, Ophthalmology | 2025 | |
| 2025-01-19 | Tarsus Pharmaceuticals, Inc. | $88 | Food and Beverage | In-kind items and services | XDEMVY Drug, DEMODEX BLEPHARITIS | 2025 | |
| 2025-01-09 | Alcon Vision LLC | $500 | Consulting Fee | Cash or cash equivalent | Voyager DSLT Device, Ophthalmology | 2025 | |
| 2024-12-31 | Beaver-Visitec International, Inc. | $5,100 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-12-10 | Sight Sciences, Inc. | $19 | Food and Beverage | In-kind items and services | TEARCARE SYSTEM Device, Ophthalmology | 2024 | |
| 2024-11-27 | Glaukos Corporation | $1,500 | Consulting Fee | Cash or cash equivalent | iDose Device, Glaucoma | 2024 | |
| 2024-11-18 | Rayner Intraocular Lenses Limited | $31 | Food and Beverage | Cash or cash equivalent | RAYNER CATARACT SET 1 Device, Opthalmology | 2024 | |
| 2024-11-07 | Sight Sciences, Inc. | $6,378 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2024 | |
| 2024-11-06 | Glaukos Corporation | $2,250 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-11-06 | Glaukos Corporation | $1,500 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-11-06 | Glaukos Corporation | $1,500 | Consulting Fee | Cash or cash equivalent | iDose Device, Glaucoma | 2024 | |
| 2024-10-30 | Glaukos Corporation | $6,000 | Consulting Fee | Cash or cash equivalent | iDose Device, Glaucoma | 2024 | |
| 2024-10-30 | Glaukos Corporation | $282 | Travel and Lodging | Cash or cash equivalent | iDose Device, Glaucoma | 2024 | |
| 2024-10-20 | Johnson & Johnson Surgical Vision, Inc. | $43 | Food and Beverage | In-kind items and services | Tecnis Simplicity Device, Optics | 2024 | |
| 2024-10-20 | Glaukos Corporation | $31 | Food and Beverage | Cash or cash equivalent | iStent Trabecular Micro-Bypass System Model iS3 Device, Glaucoma | 2024 | |
| 2024-10-09 | Alcon Vision LLC | $18 | Food and Beverage | In-kind items and services | HYDRUS Microstent Device, Ophthalmology | 2024 | |
| 2024-09-25 | Glaukos Corporation | $1,500 | Consulting Fee | Cash or cash equivalent | iDose Device, Glaucoma | 2024 | |
| 2024-09-18 | Glaukos Corporation | $2,025 | Travel and Lodging | Cash or cash equivalent | iDose Device, Glaucoma | 2024 | |
| 2024-09-18 | Glaukos Corporation | $321 | Food and Beverage | Cash or cash equivalent | iDose Device, Glaucoma | 2024 | |
| 2024-09-18 | Dompe US, Inc. | $33 | Food and Beverage | In-kind items and services | OXERVATE Drug, SOLUTION/ DROPS | 2024 | |
| 2024-08-28 | Glaukos Corporation | $1,500 | Consulting Fee | Cash or cash equivalent | iStent Trabecular Micro-Bypass System Model iS3 Device, Glaucoma | 2024 | |
| 2024-08-14 | Alcon Vision LLC | $18 | Food and Beverage | In-kind items and services | HYDRUS Microstent Device, Ophthalmology | 2024 | |
| 2024-08-13 | RxSight Inc | $24 | Food and Beverage | In-kind items and services | RXSIGHT CONTACT LENS Device, OPHTHALMOLOGY | 2024 | |
| 2024-07-26 | Glaukos Corporation | $13 | Food and Beverage | Cash or cash equivalent | iStent inject Trabecular Micro-Bypass System Device, Glaucoma | 2024 | |
| 2024-07-24 | Glaukos Corporation | $1,500 | Consulting Fee | Cash or cash equivalent | iDose Device, Glaucoma | 2024 | |
| 2024-06-24 | BIOTISSUE HOLDINGS INC. | $20 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-06-12 | Glaukos Corporation | $3,000 | Consulting Fee | Cash or cash equivalent | iDose Device, Glaucoma | 2024 | |
| 2024-05-16 | Alcon Vision LLC | $19 | Food and Beverage | In-kind items and services | HYDRUS Microstent Device, Ophthalmology | 2024 | |
| 2024-05-15 | Glaukos Corporation | $5,250 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-05-08 | RxSight Inc | $2,000 | Consulting Fee | Cash or cash equivalent | RXSIGHT CONTACT LENS Device, OPHTHALMOLOGY | 2024 | |
| 2024-05-06 | RxSight Inc | $166 | Research payment | In-kind items and services | RXSIGHT CONTACT LENS Device, OPHTHALMOLOGY | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-04-24 | Glaukos Corporation | $130 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-04-17 | Glaukos Corporation | $2,625 | Consulting Fee | Cash or cash equivalent | iDose Device, Glaucoma | 2024 | |
| 2024-04-08 | RxSight Inc | $183 | Travel and Lodging | In-kind items and services | RXSIGHT CONTACT LENS Device, OPHTHALMOLOGY | 2024 | |
| 2024-04-08 | RxSight Inc | $163 | Food and Beverage | In-kind items and services | RXSIGHT CONTACT LENS Device, OPHTHALMOLOGY | 2024 | |
| 2024-04-08 | RxSight Inc | $57 | Travel and Lodging | In-kind items and services | RXSIGHT CONTACT LENS Device, OPHTHALMOLOGY | 2024 | |
| 2024-04-07 | Alcon Vision LLC | $50 | Food and Beverage | In-kind items and services | Device, Ophthalmology | 2024 | |
| 2024-04-07 | Sight Sciences, Inc. | $19 | Food and Beverage | In-kind items and services | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2024 | |
| 2024-03-26 | Glaukos Corporation | $77 | Food and Beverage | Cash or cash equivalent | iDose Device, Glaucoma | 2024 | |
| 2024-03-26 | Glaukos Corporation | $67 | Food and Beverage | Cash or cash equivalent | iDose Device, Glaucoma | 2024 | |
| 2024-03-13 | Sight Sciences, Inc. | $21 | Food and Beverage | In-kind items and services | TEARCARE SYSTEM Device, Ophthalmology | 2024 | |
| 2024-03-06 | Sight Sciences, Inc. | $21 | Food and Beverage | In-kind items and services | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2024 | |
| 2024-03-05 | Alcon Vision LLC | $15 | Food and Beverage | In-kind items and services | Clareon Device, Ophthalmology | 2024 | |
| 2024-02-19 | Harrow Eye, LLC | $24 | Food and Beverage | In-kind items and services | IHEEZO Drug, OPTOMETRY | 2024 | |
| 2024-02-12 | Alcon Vision LLC | $25 | Food and Beverage | In-kind items and services | Clareon Device, Ophthalmology | 2024 | |
| 2024-02-07 | Johnson & Johnson Surgical Vision, Inc. | $4,550 | Consulting Fee | Cash or cash equivalent | One Series Ultra Device, Optics | 2024 | |
| 2024-01-22 | RxSight Inc | $28 | Food and Beverage | In-kind items and services | RXSIGHT CONTACT LENS Device, OPHTHALMOLOGY | 2024 | |
| 2024-01-16 | Johnson & Johnson Vision Care, Inc. | $169 | Food and Beverage | In-kind items and services | Tecnis Simplicity Device, Optics | 2024 | |
| 2024-01-15 | Glaukos Corporation | $68 | Food and Beverage | Cash or cash equivalent | iStent Trabecular Micro-Bypass System Model iS3 Device, Glaucoma | 2024 | |
| 2024-01-14 | Johnson & Johnson Vision Care, Inc. | $28 | Food and Beverage | In-kind items and services | Tecnis Simplicity Device, Optics | 2024 | |
| 2024-01-08 | BIOTISSUE HOLDINGS INC. | $13 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-01-06 | Alcon Vision LLC | $20 | Food and Beverage | In-kind items and services | ARGOS Device, Ophthalmology | 2024 | |
| 2023-12-31 | RxSight Inc | $15,000 | Consulting Fee | Cash or cash equivalent | RXSIGHT CONTACT LENS Device, OPHTHALMOLOGY | 2023 | |
| 2023-12-20 | Alcon Vision LLC | $11 | Food and Beverage | In-kind items and services | HYDRUS Microstent Device, Ophthalmology | 2023 | |
| 2023-12-07 | Alcon Vision LLC | $14 | Food and Beverage | In-kind items and services | ARGOS Device, Ophthalmology | 2023 | |
| 2023-12-06 | Glaukos Corporation | $1,500 | Consulting Fee | Cash or cash equivalent | iStent inject Trabecular Micro-Bypass System Model G2-M-IS Device, Glaucoma | 2023 | |
| 2023-12-01 | RxSight Inc | $23,685 | Consulting Fee | Cash or cash equivalent | RXSIGHT CONTACT LENS Device, OPHTHALMOLOGY | 2023 | |
| 2023-11-21 | Glaukos Corporation | $3,000 | Consulting Fee | Cash or cash equivalent | iStent Trabecular Micro-Bypass Stent System Device, Glaucoma | 2023 | |
| 2023-11-20 | Alcon Vision LLC | $50 | Food and Beverage | In-kind items and services | Clareon Device, Ophthalmology | 2023 | |
| 2023-11-16 | Alcon Vision LLC | $303 | Travel and Lodging | In-kind items and services | ARGOS Device, Ophthalmology | 2023 | |
| 2023-11-16 | Alcon Vision LLC | $178 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-11-16 | Alcon Vision LLC | $14 | Food and Beverage | In-kind items and services | Device, Ophthalmology | 2023 | |
| 2023-11-14 | RxSight Inc | $5,976 | Consulting Fee | Cash or cash equivalent | RXSIGHT CONTACT LENS Device, OPHTHALMOLOGY | 2023 | |
| 2023-10-19 | Oyster Point Pharma, Inc. | $13 | Food and Beverage | In-kind items and services | TYRVAYA Drug, DRY EYE | 2023 | |
| 2023-10-18 | Glaukos Corporation | $1,500 | Consulting Fee | Cash or cash equivalent | iStent Trabecular Micro-Bypass Stent System Device, Glaucoma | 2023 | |
| 2023-10-03 | Alcon Vision LLC | $14 | Food and Beverage | In-kind items and services | HYDRUS Microstent Device, Ophthalmology | 2023 | |
| 2023-09-06 | Glaukos Corporation | $1,500 | Consulting Fee | Cash or cash equivalent | iStent Trabecular Micro-Bypass Stent System Device, Glaucoma | 2023 | |
| 2023-09-01 | RxSight Inc | $334 | Research payment | In-kind items and services | RXSIGHT CONTACT LENS Device, OPHTHALMOLOGY | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2023 |
| 2023-08-01 | RxSight Inc | $334 | Research payment | In-kind items and services | RXSIGHT INJECTOR HANDPIECE Device, OPHTHALMOLOGY | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2023 |
| 2023-08-01 | Alcon Vision LLC | $14 | Food and Beverage | In-kind items and services | HYDRUS Microstent Device, Ophthalmology | 2023 | |
| 2023-07-19 | RxSight Inc | $25 | Honoraria | In-kind items and services | RXSIGHT CONTACT LENS Device, OPHTHALMOLOGY | 2023 | |
| 2023-07-01 | RxSight Inc | $334 | Research payment | In-kind items and services | RXSIGHT CONTACT LENS Device, OPHTHALMOLOGY | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2023 |
| 2023-06-27 | RxSight Inc | $20 | Food and Beverage | In-kind items and services | RXSIGHT CONTACT LENS Device, OPHTHALMOLOGY | 2023 | |
| 2023-06-23 | Alcon Vision LLC | $14 | Food and Beverage | In-kind items and services | HYDRUS Microstent Device, Ophthalmology | 2023 | |
| 2023-06-21 | Rayner Intraocular Lenses Limited | $19 | Food and Beverage | Cash or cash equivalent | Omidria Drug, Ophthalmology | 2023 | |
| 2023-06-01 | RxSight Inc | $334 | Research payment | In-kind items and services | RXSIGHT INJECTOR HANDPIECE Device, OPHTHALMOLOGY | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2023 |
| 2023-05-24 | Alcon Vision LLC | $14 | Food and Beverage | In-kind items and services | HYDRUS Microstent Device, Ophthalmology | 2023 | |
| 2023-05-19 | ABBVIE INC. | $450 | Consulting Fee | Cash or cash equivalent | DURYSTA Drug, EYE CARE | 2023 | |
| 2023-05-17 | Glaukos Corporation | $750 | Consulting Fee | Cash or cash equivalent | iStent inject Trabecular Micro-Bypass System Model G2-M-IS Device, Glaucoma | 2023 | |
| 2023-05-07 | Alcon Vision LLC | $46 | Food and Beverage | In-kind items and services | Opti-Free Express Device, Ophthalmology | 2023 | |
| 2023-05-05 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2023 | |
| 2023-05-01 | RxSight Inc | $334 | Research payment | In-kind items and services | RXSIGHT INJECTOR HANDPIECE Device, OPHTHALMOLOGY | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2023 |
| 2023-04-01 | RxSight Inc | $334 | Research payment | In-kind items and services | RXSIGHT CONTACT LENS Device, OPHTHALMOLOGY | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2023 |
| 2023-03-30 | Alcon Vision LLC | $16 | Food and Beverage | In-kind items and services | Rocklatan Drug, Ophthalmology | 2023 | |
| 2023-03-28 | Novartis Pharmaceuticals Corporation | $23 | Food and Beverage | In-kind items and services | XIIDRA Drug, Ophthalmology | 2023 | |
| 2023-03-20 | Beaver-Visitec International, Inc. | $238,264 | Research payment | Cash or cash equivalent | 2023 | ||
| 2023-03-20 | Alcon Vision LLC | $11 | Food and Beverage | In-kind items and services | HYDRUS Microstent Device, Ophthalmology | 2023 | |
| 2023-03-01 | RxSight Inc | $334 | Research payment | In-kind items and services | RXSIGHT INJECTOR HANDPIECE Device, OPHTHALMOLOGY | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2023 |
| 2023-02-22 | Thea Pharma Inc. | $975 | Consulting Fee | Cash or cash equivalent | IYUZEH Drug, OPHTHALMOLOGY | 2023 | |
| 2023-02-22 | ABBVIE INC. | $450 | Consulting Fee | Cash or cash equivalent | LATISSE Drug, FACIAL AESTHETICS | 2023 | |
| 2023-02-21 | Alcon Vision LLC | $2 | Food and Beverage | In-kind items and services | HYDRUS Microstent Device, Ophthalmology | 2023 | |
| 2023-02-10 | RxSight Inc | $3,284 | Consulting Fee | Cash or cash equivalent | RXSIGHT CONTACT LENS Device, OPHTHALMOLOGY | 2023 | |
| 2023-02-02 | ABBVIE INC. | $1,350 | Consulting Fee | Cash or cash equivalent | LUMIGAN Drug, EYE CARE | 2023 | |
| 2023-02-01 | RxSight Inc | $334 | Research payment | In-kind items and services | RXSIGHT CONTACT LENS Device, OPHTHALMOLOGY | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2023 |
| 2023-01-27 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2023 | |
| 2023-01-17 | Alcon Vision LLC | $55 | Food and Beverage | In-kind items and services | HYDRUS Microstent Device, Ophthalmology | 2023 | |
| 2023-01-17 | ABBVIE INC. | $39 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2023 | |
| 2023-01-01 | RxSight Inc | $334 | Research payment | In-kind items and services | RXSIGHT INJECTOR HANDPIECE Device, OPHTHALMOLOGY | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2023 |
| 2022-12-21 | Glaukos Corporation | $85 | Food and Beverage | Cash or cash equivalent | 2022 | ||
| 2022-12-21 | Glaukos Corporation | $29 | Travel and Lodging | Cash or cash equivalent | 2022 | ||
| 2022-12-06 | Alcon Vision LLC | $16 | Food and Beverage | In-kind items and services | HYDRUS Microstent Device, Ophthalmology | 2022 | |
| 2022-12-01 | Sight Sciences, Inc. | $89 | Food and Beverage | In-kind items and services | OMNI(R) SURGICAL SYSTEM (US) Device, Ophthalmology | 2022 | |
| 2022-12-01 | Sight Sciences, Inc. | $7 | Food and Beverage | In-kind items and services | OMNI(R) SURGICAL SYSTEM (US) Device, Ophthalmology | 2022 | |
| 2022-10-26 | Glaukos Corporation | $750 | Consulting Fee | Cash or cash equivalent | ISTENT INJECT W Device, GLAUCOMA | 2022 | |
| 2022-10-19 | Sight Sciences, Inc. | $3,000 | Consulting Fee | Cash or cash equivalent | OMNI(R) SURGICAL SYSTEM (US) Device, Ophthalmology | 2022 | |
| 2022-10-01 | RxSight Inc | $104 | Research payment | In-kind items and services | LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) Device, Ophthalmology | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2022 |
| 2022-06-27 | Horizon Therapeutics plc | $14 | Food and Beverage | In-kind items and services | TEPEZZA Drug, TEPEZZA | 2022 | |
| 2022-06-20 | RxSight Inc | $20 | Food and Beverage | In-kind items and services | LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) Device, Ophthalmology | 2022 | |
| 2022-05-17 | RxSight Inc | $79 | Research payment | In-kind items and services | LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) Device, Ophthalmology | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2022 |
| 2022-05-11 | Sight Sciences, Inc. | $4,500 | Consulting Fee | Cash or cash equivalent | OMNI(R) SURGICAL SYSTEM (US) Device, Ophthalmology | 2022 | |
| 2022-05-10 | Sight Sciences, Inc. | $10 | Food and Beverage | In-kind items and services | OMNI(R) SURGICAL SYSTEM (US) Device, Ophthalmology | 2022 | |
| 2022-05-03 | Glaukos Corporation | $750 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2022-04-25 | Alcon Vision LLC | $49 | Food and Beverage | In-kind items and services | AcrySof IQ VIVITY Device, Ophthalmology | 2022 | |
| 2022-04-08 | Glaukos Corporation | $10 | Food and Beverage | Cash or cash equivalent | KXL SYSTEM Device, KERATOCONUS | 2022 | |
| 2022-04-08 | Glaukos Corporation | $9 | Food and Beverage | Cash or cash equivalent | Device, CORNEAL HEALTH | 2022 | |
| 2022-04-07 | ABBVIE INC. | $1,125 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | XEN GLAUCOMA TREATMENT SYSTEM Device, GLAUCOMA | 2022 | |
| 2022-03-21 | Allergan, Inc. | $225 | Consulting Fee | Cash or cash equivalent | XEN GLAUCOMA TREATMENT SYSTEM Device, GLAUCOMA | 2022 | |
| 2022-03-21 | RxSight Inc | $35 | Food and Beverage | In-kind items and services | LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) Device, Ophthalmology | 2022 | |
| 2022-03-09 | Sight Sciences, Inc. | $1,850 | Consulting Fee | Cash or cash equivalent | OMNI(R) SURGICAL SYSTEM (US) Device, Ophthalmology | 2022 | |
| 2022-02-24 | Novartis Pharmaceuticals Corporation | $19 | Food and Beverage | In-kind items and services | XIIDRA Drug, OPHTHALMOLOGY | 2022 | |
| 2022-02-22 | Sight Sciences, Inc. | $11 | Food and Beverage | In-kind items and services | OMNI(R) SURGICAL SYSTEM (US) Device, Ophthalmology | 2022 | |
| 2022-02-08 | Johnson & Johnson Surgical Vision, Inc. | $1,150 | Consulting Fee | Cash or cash equivalent | One Series Ultra Device, Optics | 2022 | |
| 2022-02-01 | NEW WORLD MEDICAL,INC. | $15 | Food and Beverage | In-kind items and services | Kahook Dual Blade Device, Ophthalmology | 2022 | |
| 2022-01-27 | Alcon Vision LLC | $19 | Food and Beverage | In-kind items and services | AcrySof IQ PanOptix UV IOL Device, Ophthalmology | 2022 | |
| 2022-01-19 | Sight Sciences, Inc. | $64 | Food and Beverage | In-kind items and services | TearCare SmartLid Device, Ophthalmology | 2022 | |
| 2022-01-18 | Glaukos Corporation | $164 | Food and Beverage | Cash or cash equivalent | ISTENT INJECT W Device, GLAUCOMA | 2022 | |
| 2021-11-18 | The Cameron-Ehlen Group, Inc. | $22 | Food and Beverage | In-kind items and services | TECNIS IOL Medical Supply, IOL PRODUCTS | 2021 | |
| 2021-10-27 | Omeros Corporation | $40 | Food and Beverage | Cash or cash equivalent | Omidria Drug, Ophthalmology | 2021 | |
| 2021-09-08 | Allergan, Inc. | $22 | Food and Beverage | In-kind items and services | XEN GLAUCOMA TREATMENT SYSTEM Device, GLAUCOMA | 2021 | |
| 2021-09-01 | Glaukos Corporation | $2,500 | Honoraria | Cash or cash equivalent | iStent inject W Device, Glaucoma | 2021 | |
| 2021-09-01 | Glaukos Corporation | $500 | Honoraria | Cash or cash equivalent | iStent inject W Device, Glaucoma | 2021 | |
| 2021-08-30 | Glaukos Corporation | $66 | Food and Beverage | Cash or cash equivalent | iStent Device, Glaucoma | 2021 | |
| 2021-08-12 | Glaukos Corporation | $2,000 | Honoraria | Cash or cash equivalent | iStent inject W Device, Glaucoma | 2021 | |
| 2021-08-12 | Glaukos Corporation | $1,500 | Honoraria | Cash or cash equivalent | iStent inject W Device, Glaucoma | 2021 | |
| 2021-08-12 | Allergan, Inc. | $400 | Consulting Fee | Cash or cash equivalent | XEN GLAUCOMA TREATMENT SYSTEM Device, GLAUCOMA | 2021 | |
| 2021-08-11 | Sight Sciences, Inc. | $2,250 | Consulting Fee | Cash or cash equivalent | OMNI(R) SURGICAL SYSTEM (US) Device, Ophthalmology | 2021 | |
| 2021-08-11 | Sight Sciences, Inc. | $750 | Consulting Fee | Cash or cash equivalent | OMNI(R) SURGICAL SYSTEM (US) Device, Ophthalmology | 2021 | |
| 2021-08-04 | Sight Sciences, Inc. | $7 | Food and Beverage | In-kind items and services | OMNI(R) SURGICAL SYSTEM (US) Device, Ophthalmology | 2021 | |
| 2021-08-04 | Sight Sciences, Inc. | $5 | Food and Beverage | In-kind items and services | OMNI(R) SURGICAL SYSTEM (US) Device, Ophthalmology | 2021 | |
| 2021-07-25 | Sight Sciences, Inc. | $59 | Food and Beverage | In-kind items and services | OMNI(R) SURGICAL SYSTEM (US) Device, Ophthalmology | 2021 | |
| 2021-07-24 | Alcon Vision LLC | $81 | Food and Beverage | In-kind items and services | AcrySof IQ PanOptix Device, Ophthalmology | 2021 | |
| 2021-07-24 | Alcon Vision LLC | $45 | Food and Beverage | In-kind items and services | Opti-Free Device, Ophthalmology | 2021 | |
| 2021-07-13 | Glaukos Corporation | $66 | Food and Beverage | In-kind items and services | iStent inject W Device, Glaucoma | 2021 | |
| 2021-06-29 | Glaukos Corporation | $1,500 | Honoraria | Cash or cash equivalent | iStent inject W Device, Glaucoma | 2021 | |
| 2021-06-17 | Sight Sciences, Inc. | $6 | Food and Beverage | In-kind items and services | OMNI(R) SURGICAL SYSTEM (US) Device, Ophthalmology | 2021 | |
| 2021-06-03 | Glaukos Corporation | $750 | Honoraria | Cash or cash equivalent | iStent inject W Device, Glaucoma | 2021 | |
| 2021-05-12 | Sight Sciences, Inc. | $50 | Food and Beverage | In-kind items and services | OMNI(R) SURGICAL SYSTEM (US) Device, Ophthalmology | 2021 | |
| 2021-05-11 | Allergan, Inc. | $1,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | XEN GLAUCOMA TREATMENT SYSTEM Device, GLAUCOMA | 2021 | |
| 2021-05-11 | Allergan, Inc. | $800 | Consulting Fee | Cash or cash equivalent | XEN GLAUCOMA TREATMENT SYSTEM Device, GLAUCOMA | 2021 |
The latest 200 records of 305.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2025-12-17 | Glaukos Corporation | Vance Thompson Vision Clinic, Prof LLC | $1,845 | A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT | 2025 |
| 2025-11-26 | Glaukos Corporation | Uh Cleveland Medical Center | $540 | iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study | 2025 |
| 2025-11-26 | Glaukos Corporation | Uh Cleveland Medical Center | $400 | A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT | 2025 |
| 2025-08-27 | Glaukos Corporation | Greenphire, Inc. | $394 | A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT | 2025 |
| 2025-08-13 | Glaukos Corporation | OCPC | $14 | A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT | 2025 |
| 2025-08-13 | Glaukos Corporation | OCPC | $59 | A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT | 2025 |
| 2025-08-13 | Glaukos Corporation | Uh Cleveland Medical Center | $2,250 | iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study | 2025 |
| 2025-08-06 | Glaukos Corporation | Vance Thompson Vision Clinic, Prof LLC | $3,250 | A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT | 2025 |
| 2025-07-23 | Glaukos Corporation | Greenphire, Inc. | $394 | A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT | 2025 |
| 2025-06-18 | Glaukos Corporation | OCPC | $17 | A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT | 2025 |
| 2025-06-11 | Glaukos Corporation | OCPC | $15 | A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT | 2025 |
| 2025-06-04 | Glaukos Corporation | Vance Thompson Vision Clinic, Prof LLC | $532 | iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study | 2025 |
| 2025-05-29 | Glaukos Corporation | Greenphire, Inc. | $197 | A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT | 2025 |
| 2025-05-29 | Glaukos Corporation | Greenphire, Inc. | $197 | A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT | 2025 |
| 2025-05-14 | Glaukos Corporation | Greenphire, Inc. | $394 | A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT | 2025 |
| 2025-05-14 | Glaukos Corporation | OCPC | $114 | A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT | 2025 |
| 2025-05-08 | Alcon Research LLC | ICON CLINICAL RESEARCH LIMITED | $1,161 | Long-term evaluation of safety and performance of Clareon Presbyopia-Correction IOLs – PMCF Study of Clareon Vivity & Cl | 2025 |
| 2025-05-07 | Glaukos Corporation | Vance Thompson Vision Clinic, Prof LLC | $1,250 | iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study | 2025 |
| 2025-04-03 | Sight Sciences, Inc. | Vance Thompson Vision Clinic Prof LLC | $1,111 | A Clinical Trial Comparing the OMNI Surgical System to Standard Medical Treatment in Patients With Primary Open Angle Gl | 2025 |
| 2025-04-03 | Sight Sciences, Inc. | Vance Thompson Vision Clinic Prof LLC | $3,000 | A Clinical Trial Comparing the OMNI Surgical System to Standard Medical Treatment in Patients With Primary Open Angle Gl | 2025 |
| 2025-04-03 | Sight Sciences, Inc. | Vance Thompson Vision Clinic Prof LLC | $123 | A Clinical Trial Comparing the OMNI Surgical System to Standard Medical Treatment in Patients With Primary Open Angle Gl | 2025 |
| 2025-04-02 | Glaukos Corporation | Vance Thompson Vision Clinic, Prof LLC | $1,250 | iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study | 2025 |
| 2025-04-02 | Glaukos Corporation | Vance Thompson Vision Clinic, Prof LLC | $7,500 | iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study | 2025 |
| 2025-04-01 | Alcon Research LLC | ICON CLINICAL RESEARCH LIMITED | $1,161 | Long-term evaluation of safety and performance of Clareon Presbyopia-Correction IOLs – PMCF Study of Clareon Vivity & Cl | 2025 |
| 2025-03-11 | Alcon Research LLC | ICON CLINICAL RESEARCH LIMITED | $1,437 | Long-term evaluation of safety and performance of Clareon Presbyopia-Correction IOLs – PMCF Study of Clareon Vivity & Cl | 2025 |
| 2025-03-05 | Glaukos Corporation | Amazon.com, Inc. | $4 | A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT | 2025 |
| 2025-02-26 | Glaukos Corporation | Greenphire, Inc. | $394 | A PROSPECTIVE, MULTICENTER STUDY OF THE GLAUKOS ISTENT INFINITE TRABECULAR MICRO-BYPASS SYSTEM MODEL IS3 IN SUBJECTS WIT | 2025 |
| 2025-02-12 | Glaukos Corporation | Vance Thompson Vision Clinic, Prof LLC | $3,750 | iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study | 2025 |
| 2025-01-07 | Alcon Research LLC | ICON CLINICAL RESEARCH LIMITED | $1,437 | Long-term evaluation of safety and performance of Clareon Presbyopia-Correction IOLs – PMCF Study of Clareon Vivity & Cl | 2025 |
| 2024-12-31 | RxSight Inc | US BANK NATIONAL ASSOCIATION | $7,446 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-12-31 | ABBVIE INC. | VANCE THOMPSON VISION CLINIC | $294 | 1924-703-007 XEN45 Ab-Ex Study (M21-507) | 2024 |
| 2024-12-31 | RxSight Inc | ADVANCING EYECARE FINANCING | $15,154 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-12-31 | RxSight Inc | LOMBART BROTHERS INC | $134 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-12-31 | RxSight Inc | KONAN MEDICAL USA | $6,250 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-12-10 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $1,500 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-12-04 | Glaukos Corporation | Vance Thompson Vision Clinic, Prof LLC | $5,000 | iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study | 2024 |
| 2024-11-08 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $150 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-11-08 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $150 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-11-06 | Glaukos Corporation | Vance Thompson Vision Clinic, Prof LLC | $3,750 | iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study | 2024 |
| 2024-10-30 | Glaukos Corporation | Uh Cleveland Medical Center | $360 | iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study | 2024 |
| 2024-10-23 | Glaukos Corporation | Uh Cleveland Medical Center | $378 | iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study | 2024 |
| 2024-10-16 | Glaukos Corporation | Uh Cleveland Medical Center | $240 | iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study | 2024 |
| 2024-10-09 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $1,110 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-10-09 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $1,000 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-10-09 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $1,000 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-10-02 | Glaukos Corporation | Vance Thompson Vision Clinic, Prof LLC | $12,500 | iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study | 2024 |
| 2024-09-24 | Glaukos Corporation | InComm Digital Solutions, LLC | $3,080 | iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study | 2024 |
| 2024-09-18 | Glaukos Corporation | Uh Cleveland Medical Center | $360 | iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study | 2024 |
| 2024-09-10 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $500 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-09-10 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $500 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-09-10 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $500 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-09-10 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $1,110 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-09-10 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $25 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-09-10 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $1,000 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-09-10 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $1,000 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-09-10 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $1,500 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-09-10 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $1,110 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-08-08 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $1,110 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-08-01 | Glaukos Corporation | Vance Thompson Vision Clinic, Prof LLC | $3,750 | iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study | 2024 |
| 2024-07-10 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $1,110 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-07-10 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $780 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-07-10 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $985 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-07-10 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $1,110 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-07-10 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $985 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-07-10 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $1,110 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-07-10 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $1,110 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-07-09 | Glaukos Corporation | InComm Digital Solutions, LLC | $3,080 | iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study | 2024 |
| 2024-07-03 | Glaukos Corporation | Uh Cleveland Medical Center | $1,350 | iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study | 2024 |
| 2024-07-03 | Glaukos Corporation | Vance Thompson Vision Clinic, Prof LLC | $200 | iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study | 2024 |
| 2024-06-13 | Alcon Research LLC | ICON CLINICAL RESEARCH LIMITED | $5,000 | Long-term evaluation of safety and performance of Clareon Presbyopia-Correction IOLs PMCF Study of Clareon Vivity & Cla | 2024 |
| 2024-06-13 | Alcon Research LLC | ICON CLINICAL RESEARCH LIMITED | $1,000 | Long-term evaluation of safety and performance of Clareon Presbyopia-Correction IOLs PMCF Study of Clareon Vivity & Cla | 2024 |
| 2024-06-08 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $530 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-06-08 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $1,550 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-06-08 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $1,550 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-06-08 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $1,550 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-06-08 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $665 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-06-08 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $665 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-06-08 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $1,110 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-06-08 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $985 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-06-08 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $1,330 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-06-08 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $1,330 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-06-08 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $1,330 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-06-08 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $1,330 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-06-08 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $1,330 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-06-08 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $1,330 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-06-08 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $635 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-06-08 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $1,330 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-06-08 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $845 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-06-08 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $845 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-06-08 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $845 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-06-08 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $750 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-06-08 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $750 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-06-08 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $1,195 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-06-08 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $530 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-06-08 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $780 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-06-08 | RxSight Inc | VANCE THOMPSON VISION CLINIC PROF LLC | $780 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | 2024 |
| 2024-06-05 | Glaukos Corporation | Vance Thompson Vision Clinic, Prof LLC | $6,450 | iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study | 2024 |
| 2024-05-22 | Glaukos Corporation | Uh Cleveland Medical Center | $450 | iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study | 2024 |
| 2024-05-21 | Alcon Research LLC | VANCE THOMPSON VISION | $73 | Long-term evaluation of safety and performance of Clareon Presbyopia-Correction IOLs PMCF Study of Clareon Vivity & Cla | 2024 |
| 2024-05-21 | Alcon Research LLC | VANCE THOMPSON VISION | $45 | Long-term evaluation of safety and performance of Clareon Presbyopia-Correction IOLs PMCF Study of Clareon Vivity & Cla | 2024 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Alexandria, MN, county Douglas County, MN, state Minnesota; placed by its city name.
| Measure | Place (city or town) Alexandria, MN | County Douglas County, MN | State Minnesota |
|---|---|---|---|
| Population B01003 | 14,735 | 39,575 | 5,739,445 |
| Population, 2020 census P1 | 14,335 | 39,006 | 5,706,494 |
| Median age B01002 | 40.8 | 44.5 | 38.8 |
| Under 18 B01001 | 20.1% | 21.4% | 22.9% |
| 65 and over B01001 | 24.4% | 24.4% | 17.3% |
| Households B11001 | 6,975 | 17,519 | 2,307,955 |
| Foreign born B05002 | 2.2% | 1.5% | 8.7% |
| Median household income B19013 | $61,374 | $79,043 | $89,062 |
| Median family income B19113 | $91,134 | $100,381 | $113,993 |
| Per capita income B19301 | $41,095 | $44,466 | $48,237 |
| Poverty rate B17001 | 12.0% | 9.0% | 9.3% |
| Unemployment rate B23025 | 3.6% | 2.9% | 4.1% |
| Civilian labor force B23025 | 7,662 | 20,161 | 3,119,042 |
| Mean commute (minutes) B08013 | 17.5 | 20.5 | 22.7 |
| Bachelor's degree or higher B15003 | 33.2% | 29.7% | 39.4% |
| Housing units B25001 | 7,715 | 22,332 | 2,545,030 |
| Owner-occupied B25003 | 57.4% | 76.5% | 72.2% |
| Renters B25003 | 42.6% | 23.5% | 27.8% |
| Median home value B25077 | $275,300 | $321,400 | $329,300 |
| Median gross rent B25064 | $934 | $927 | $1,280 |
| White, not Hispanic B03002 | 89.6% | 93.7% | 75.9% |
| Black B03002 | 0.9% | 0.5% | 6.9% |
| Hispanic or Latino B03002 | 4.6% | 2.3% | 6.4% |
| Asian B03002 | 0.6% | 0.5% | 5.1% |
| American Indian and Alaska Native B03002 | 0.1% | 0.2% | 0.7% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Alexandria, MN.
Comments